Unveiling Skeletal Fragility in Patients Diagnosed With MGUS: No Longer a Condition of Undetermined Significance?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unveiling Skeletal Fragility in Patients Diagnosed With MGUS: No Longer a Condition of Undetermined Significance?
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 29, Issue 12, Pages 2529-2533
Publisher
Wiley
Online
2014-10-15
DOI
10.1002/jbmr.2387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fracture mortality: associations with epidemiology and osteoporosis treatment
- (2014) Sebastian E. Sattui et al. Nature Reviews Endocrinology
- Altered cortical microarchitecture in patients with monoclonal gammopathy of undetermined significance
- (2013) J. N. Farr et al. BLOOD
- International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease
- (2013) Evangelos Terpos et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease
- (2013) Ida B. Kristensen et al. LEUKEMIA & LYMPHOMA
- Osteoporosis and Cancer
- (2013) Matthew T. Drake Current Osteoporosis Reports
- Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation
- (2012) N Giuliani et al. LEUKEMIA
- Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition
- (2012) Terry M. Therneau et al. MAYO CLINIC PROCEEDINGS
- A systematic review of hip fracture incidence and probability of fracture worldwide
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1 levels in patients with MGUS
- (2011) A. C. Ng et al. BLOOD
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies
- (2011) N. Korde et al. BLOOD
- Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma
- (2011) Noopur Raje et al. CLINICAL CANCER RESEARCH
- Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post-bortezomib monotherapy
- (2011) Evangelos Terpos et al. INTERNATIONAL JOURNAL OF CANCER
- Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects
- (2011) V. Bousson et al. OSTEOPOROSIS INTERNATIONAL
- The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008
- (2011) B. Dawson-Hughes et al. OSTEOPOROSIS INTERNATIONAL
- Interpretation and use of FRAX in clinical practice
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Bone Disease From Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: Pathogenesis, Interventions, and Future Opportunities
- (2011) Alex R. Minter et al. SEMINARS IN HEMATOLOGY
- Myeloma cells suppress osteoblasts through sclerostin secretion
- (2011) S Colucci et al. Blood Cancer Journal
- Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study
- (2010) S. Y. Kristinsson et al. BLOOD
- Tumor–host cell interactions in the bone disease of myeloma
- (2010) Jessica A. Fowler et al. BONE
- The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group
- (2010) E Terpos et al. LEUKEMIA
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
- (2010) R A Kyle et al. LEUKEMIA
- Prevalence of Monoclonal Gammopathy of Undetermined Significance: A Systematic Review
- (2010) Rishi K. Wadhera et al. MAYO CLINIC PROCEEDINGS
- The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
- (2009) E. Terpos et al. ANNALS OF ONCOLOGY
- Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma
- (2009) M Roussou et al. LEUKEMIA
- Disease Associations With Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 17,398 Patients
- (2009) John P. Bida et al. MAYO CLINIC PROCEEDINGS
- Prevalence of Monoclonal Gammopathy of Undetermined Significance/Myeloma in Patients with Acute Osteoporotic Vertebral Fractures
- (2008) Terry Golombick et al. ACTA HAEMATOLOGICA
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pathogenesis of myeloma bone disease
- (2008) G D Roodman LEUKEMIA
- Secondary contributors to bone loss in osteoporosis related hip fractures
- (2008) B. J. Edwards et al. OSTEOPOROSIS INTERNATIONAL
- Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
- (2008) B. Dawson-Hughes et al. OSTEOPOROSIS INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started